Table 1.
Author (year) | ADSCs origin | Additional agents | Delivery | Route of delivery | Lymphangiogenesis or LE improvement | Paracrine action | Differentiation into LEC |
---|---|---|---|---|---|---|---|
Takeda et al. (2015) [20] | Animal | - | - | - | Yes | Yes | No |
Strassburg et al. (2016) [17] | Human | VEGF-C | Culture media | - | Yes | Yes | No |
Deng et al. (2017) [18] | Human | Prox-1 | Virus | - | Yes | Yes | Yes |
Saijo et al. (2019) [21] | Human | Irradiation | - | Yes | Yes | No | |
Sun et al. (2019) [19] | Human | IL-7 | Culture media | - | Yes | Yes | Yes |
Yan et al. (2011) [16] | Animal | VEGF-C | Culture media | Implanted Matrigel plug | Yes | Yes | Yes |
TGF-β1 inhibition | Virus |
ADSCs, adipose-derived stem cells; LE, lymphedema; LEC, lymphatic endothelial cell; VEGF, vascular endothelial growth factor; Prox-1, prospero homeobox protein 1; IL, interleukin; TGF, transforming growth factor.